Table 5.
Comparison of 30-day mortality between young (age ≤45 and older (age >45) Malaysian women presented as unadjusted and adjusted risk ratio (RR) with 95% CI
| Number of patients | Deaths n (%) |
Unadjusted risk ratio (95% CI) | P value | Adjusted risk ratio* (95% CI) | P value | |
| All patients (n=5872) | ||||||
| Young women | 292 | 18 (6.2%) | Reference | Reference | ||
| Older women | 5580 | 853 (15.3) | 8.01 (7.01 to 9.56) | <0.001 | 8.57 (7.85 to 10.12) | <0.001 |
| STEMI (n=2810) | ||||||
| Young women | 188 | 15 (8.0%) | Reference | Reference | ||
| Older women | 2622 | 490 (18.7%) | 9.05 (8.09 to 11.34) | <0.001 | 9.87 (9.01 to 12.93) | <0.001 |
| NSTEMI (n=3062) | ||||||
| Young women | 102 | 3 (2.9%) | Reference | Reference | ||
| Older women | 2958 | 363 (12.3%) | 8.95 (7.41 to 9.21) | 0.004 | 9.08 (7.98 to 10.82) | 0.002 |
*Adjusted for are age, ethnicity, dyslipidaemia, hypertension, diabetes, family history of premature CAD, chronic renal failure, Killip Class, door to needle time, aspirin, statin and PCI.